Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Young on Delaney

Executive Summary

In a discussion of the increased burden on the agency related to food "scares" such as the recent uproar over trace amounts of Alar in apples, FDA Commissioner Young told the House Appropriations/Agriculture Subcommittee at an April 10 hearing that Congress must "deal with the Delaney issue." He also cited FD&C Red 3 as an example of the "terrible problem" caused by the Delaney Clause. Under a de minimis analysis, the color additive is "safe," Young said, while a rigid interpretation of the law appears to dictate otherwise.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS015459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel